Expanding Emerging Markets And Diagnostics Will Drive Prospects Despite Headwinds

Shared on07 May 25
Fair value Increased 0.58%

Shared on30 Apr 25
Fair value Increased 0.93%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 2.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 1.82%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 5.78%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to 0.0%.